Katherine Bunge

2.5k total citations
37 papers, 892 citations indexed

About

Katherine Bunge is a scholar working on Infectious Diseases, Microbiology and Epidemiology. According to data from OpenAlex, Katherine Bunge has authored 37 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 18 papers in Microbiology and 14 papers in Epidemiology. Recurrent topics in Katherine Bunge's work include HIV/AIDS Research and Interventions (25 papers), Reproductive tract infections research (18 papers) and Adolescent Sexual and Reproductive Health (12 papers). Katherine Bunge is often cited by papers focused on HIV/AIDS Research and Interventions (25 papers), Reproductive tract infections research (18 papers) and Adolescent Sexual and Reproductive Health (12 papers). Katherine Bunge collaborates with scholars based in United States, South Africa and Uganda. Katherine Bunge's co-authors include Sharon L. Hillier, Leslie A. Meyn, Jeffrey P. Froehlich, B. Rezai, Linda Cheng, Ralph H. Hruban, James L. Kinsella, William L. Hunter, Steven J. Sollott and Alan W. Heldman and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Katherine Bunge

37 papers receiving 867 citations

Peers

Countries citing papers authored by Katherine Bunge

Since Specialization

Citations

This map shows the geographic impact of Katherine Bunge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Bunge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Bunge more than expected).

Fields of papers citing papers by Katherine Bunge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Bunge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Bunge. The network helps show where Katherine Bunge may publish in the future.

Co-authorship network of co-authors of Katherine Bunge

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Bunge. A scholar is included among the top collaborators of Katherine Bunge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Bunge. Katherine Bunge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial 2025 ·The Lancet HIV ·Lisa Noguchi, Maxensia Owor, Nyaradzo Mgodi, Brenda Gati Mirembe, Sufia Dadabhai, Elizea Horne, Holly Gundacker, Barbra A. Richardson, Katherine Bunge, Rachel Scheckter, Mei Song, Mark A. Marzinke, Peter L. Anderson, Edward Livant, Cindy Jacobson, Jeanna Piper, Nahida Chakhtoura, Sharon L. Hillier, Jennifer E. Balkus	3
2	Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus 2024 ·Clinical Infectious Diseases ·Catherine A. Chappell, Jennifer J. Kiser, Kristina M. Brooks, Randy Randolph, Ingrid Macio, Leslie A. Meyn, (unknown), Anne-Marie Rick, Gysella Muñiz, (unknown), (unknown), (unknown), Bruce Kreter, Katherine Bunge, Elizabeth E. Krans, Sharon L. Hillier	2
3	Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States 2024 ·Journal of the International AIDS Society ·Albert Liu, Holly Gundacker, Barbra A. Richardson, Beatrice A. Chen, Craig Hoesley, Ariane van der Straten, Amanda Brown, May A. Beamer, Jennifer Robinson, Cindy Jacobson, Rachel Scheckter, Katherine Bunge, Jill L. Schwartz, Andrea R. Thurman, Jeanna Piper, Mark A. Marzinke, (unknown)	1
4	Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe 2024 ·AIDS and Behavior ·(unknown), Marie C. D. Stoner, Florence Mathebula, (unknown), (unknown), (unknown), Prisca Mutero, Juliane Etima, (unknown), Lee Fairlie, Ashley Mayo, Jennifer E. Balkus, Mei Song, Katherine Bunge, Jeanna Piper, Iván C. Balán, Ariane van der Straten, Elizabeth Montgomery	3
5	Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States 2021 ·Journal of the International AIDS Society ·Albert Liu, (unknown), Holly Gundacker, Blažej Neradilek, Craig Hoesley, Ariane van der Straten, Craig W. Hendrix, May A. Beamer, Cindy Jacobson, (unknown), Tanya M. Harrell, Katherine Bunge, Bríd Devlin, Jeremy Nuttall, Patrick Spence, John Steytler, Jeanna Piper, Mark A. Marzinke, (unknown)	17
6	Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy 2021 ·SHILAP Revista de lepidopterología ·Erica M. Lokken, (unknown), Katherine Bunge, Lee Fairlie, Bonus Makanani, Richard H. Beigi, Lisa Noguchi, Jennifer E. Balkus	11
7	Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review 2021 ·PLoS ONE ·Jennifer E. Balkus, Moni B. Neradilek, Lee Fairlie, Bonus Makanani, Nyaradzo Mgodi, Felix Mhlanga, Clemensia Nakabiito, Ashley Mayo, Tanya M. Harrell, Jeanna Piper, Katherine Bunge, (unknown)	10
8	Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study 2020 ·The Lancet Microbe ·Catherine A. Chappell, Kimberly K. Scarsi, Brian Kirby, Vithika Suri, Anuj Gaggar, Debra L. Bogen, Ingrid Macio, Leslie A. Meyn, Katherine Bunge, Elizabeth E. Krans, Sharon L. Hillier	78
9	Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women 2020 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Katherine Bunge, Lisa Levy, Daniel Szydlo, Jingyang Zhang, Aditya H. Gaur, (unknown), Kenneth H. Mayer, Donna Futterman, Craig Hoesley, Sharon L. Hillier, Mark A. Marzinke, Craig W. Hendrix, Pamina M. Gorbach, Craig M. Wilson, Lydia Soto‐Torres, Bill G. Kapogiannis, Annaléne Nel, Kathleen Squires, (unknown)	20
10	Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study 2019 ·Contraception ·Catherine A. Chappell, Ishana Harkoo, Daniel Szydlo, Katherine Bunge, Devika Singh, Clemensia Nakabiito, Felix Mhlanga, (unknown), Jeanna Piper, Jennifer E. Balkus, Sharon L. Hillier	5
11	Bacterial species colonizing the vagina of healthy women are not associated with race 2017 ·Anaerobe ·May A. Beamer, Michele N. Austin, (unknown), Leslie A. Meyn, Katherine Bunge, Sharon L. Hillier	30
12	Heterogeneity of HIV-1 Replication in Ectocervical and Vaginal Tissue Ex Vivo 2017 ·AIDS Research and Human Retroviruses ·Charlene S. Dezzutti, Seo Young Park, (unknown), (unknown), (unknown), Ingrid Macio, Catherine A. Chappell, Katherine Bunge	5
13	Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial 2017 ·Journal of Women s Health ·Carolyne A. Akello, Katherine Bunge, Clemensia Nakabiito, Brenda Gati Mirembe, Mary Glenn Fowler, Anupam Mishra, Jeanne Marrazzo, Zvavahera M. Chirenje, Connie Celum, Jennifer E. Balkus	5
14	A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Katherine Bunge, Charlene S. Dezzutti, Lisa C. Rohan, Craig W. Hendrix, Mark A. Marzinke, Nicola Richardson‐Harman, Bernard J. Moncla, Bríd Devlin, Leslie A. Meyn, Hans Spiegel, Sharon L. Hillier	58
15	The effects of reproductive hormones on the physical properties of cervicovaginal fluid 2014 ·American Journal of Obstetrics and Gynecology ·Catherine A. Chappell, Lisa C. Rohan, Bernard J. Moncla, (unknown), Leslie A. Meyn, Katherine Bunge, Sharon L. Hillier	44
16	The Effects of Hormones and Vaginal Microflora on the Content of MUC1, MUC4, MUC5AC and MUC7 in the Cervicovaginal Fluid (CVF) 2014 ·AIDS Research and Human Retroviruses ·Bernard J. Moncla, Catherine A. Chappell, Brian Debo, Ingrid Macio, Katherine Bunge, Sharon L. Hillier	1
17	HIV-1 Infection of Female Genital Tract Tissue for Use in Prevention Studies 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Charlene S. Dezzutti, (unknown), Katherine Bunge, Nicola Richardson‐Harman, Ingrid Macio, Sharon L. Hillier	31
18	Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide 2011 ·AIDS Research and Therapy ·Alexandra B. Sassi, Katherine Bunge, Brian L. Hood, Thomas P. Conrads, Alexander M. Cole, Phalguni Gupta, Lisa C. Rohan	15
19	The Efficacy of Retreatment With the Same Medication for Early Treatment Failure of Bacterial Vaginosis 2009 ·Sexually Transmitted Diseases ·Katherine Bunge, Richard H. Beigi, Leslie A. Meyn, Sharon L. Hillier	20
20	Epidemiologic and Economic Effect of Methicillin-Resistant Staphylococcus aureus in Obstetrics 2009 ·Obstetrics and Gynecology ·Richard H. Beigi, Katherine Bunge, Yeohan Song, Bruce Y. Lee	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact